On a roll, AstraZeneca flags looming approvals for three big drug franchises - Endpoints News

AstraZeneca celebrated a PR trifecta Monday morning, nabbing a pair of EU recommendations for two of their latest blockbusters along with a priority review for a third from the FDA. Their asthma franchise nabbed a thumbs-up from the CHMP for Tezspire as an ad…

Five years after Amgen buried its CETP cholesterol drug, a Dutch biotech with hundreds of millions in funding is headed to Wall Street to continue testing the therapy in Phase III trials. A month af… [+616 chars]

full article...